Receipt of Order passed by the Hon''ble NCLT, Chennai Bench, in relation to the Scheme of Amalgamation between Dr. Agarwal''s Eye Hospital Limited and Dr. Agarwal''s Health Care Limited, is attached.
DRAGARWQ · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.5 pts more than Nifty Microcap 250 and 0.8 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The Hon'ble NCLT, Chennai Bench has passed an order on May 5, 2026, allowing the joint First Motion Application for the amalgamation of Dr. Agarwal's Eye Hospital Limited (AEHL) and Dr. Agarwal's Health Care Limited (AHCL). The tribunal has directed both companies to convene meetings of their equity shareholders, secured creditors, and unsecured creditors on July 2, 2026, to consider and approve the scheme. This is a procedural step under Sections 230-232 of the Companies Act, 2013. The scheme remains subject to further statutory and regulatory approvals after the meetings.
This is a positive procedural development as the NCLT has approved the scheme for shareholder and creditor consideration. Pending approvals at the July 2026 meetings and subsequent regulatory clearances, the amalgamation would combine both entities under a unified structure.